[email protected] +91 9789129171
ICHOC · Registering as Listener

International Conference on Hematology and Oncology Collaboration

11 - 12 Nov 2026 Manila, Philippines Standard / Physical Participation
Listener Registration
$120
virtual · $135 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICHOC
ModeStandard / Physical
ParticipationListener
Registration fee$135.00
Bank charges (5.8%)$7.83
Total payable$142.83
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICHOC conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Innovations in Molecular Diagnostics +
This track will explore the latest advancements in molecular diagnostic techniques and their applications in hematology and oncology. Emphasis will be placed on how these innovations can enhance patient outcomes through early detection and personalized treatment strategies.
02 Translational Research in Hematology +
This session will focus on the translation of laboratory findings into clinical applications within hematology. Participants will discuss the challenges and successes of bridging the gap between research and patient care.
03 Therapeutic Strategies in Cancer Treatment +
This track will examine current and emerging therapeutic strategies for treating hematological malignancies. Discussions will include targeted therapies, immunotherapy, and combination treatment approaches.
04 Clinical Trials in Hematology and Oncology +
This session will highlight the design and implementation of clinical trials specifically targeting hematological cancers. Participants will share insights on trial methodologies, patient recruitment, and regulatory considerations.
05 Patient Care and Quality of Life +
This track will address the importance of patient-centered care in hematology and oncology. Topics will include psychosocial support, symptom management, and strategies to improve the quality of life for patients.
06 Laboratory Innovations in Hematology +
This session will showcase cutting-edge laboratory techniques and technologies that are transforming hematology diagnostics and research. Emphasis will be placed on automation, high-throughput screening, and novel biomarker discovery.
07 Collaboration in Cancer Research +
This track will explore the significance of interdisciplinary collaboration in advancing cancer research. Participants will discuss successful models of partnership between academia, industry, and clinical practice.
08 Understanding Disease Mechanisms +
This session will delve into the underlying biological mechanisms of hematological diseases. Presentations will focus on genetic, epigenetic, and environmental factors contributing to disease pathogenesis.
09 Emerging Trends in Hematology +
This track will highlight recent trends and future directions in hematology research and treatment. Topics will include novel therapies, advancements in genetic research, and the impact of technology on patient management.
10 Ethical Considerations in Hematology and Oncology +
This session will address the ethical challenges faced in hematology and oncology research and practice. Discussions will include informed consent, equity in clinical trials, and the implications of personalized medicine.
11 Global Perspectives on Hematology and Oncology +
This track will provide a platform for discussing global health challenges and disparities in hematology and oncology. Participants will share insights on international collaborations and strategies to improve access to care.